Women's Health Archive

Pap tests, the mainstay screening method to detect cervical cancer, are uncomfortable for some women. In mid-2024, the FDA approved a new self-swab test that can detect human papillomavirus, which causes most cases of cervical cancer. The self-swab test collects cells from the vaginal wall instead of the cervix. Clinicians guide women on how to perform the test in a doctor's office. The self-swab method offers women several benefits, including comfort, accuracy, and potentially greater access to screening.

The experience of sexual violence may have later effects on both physical and emotional health. Being aware of these possibilities can help you identify and respond to them promptly.

A 2024 study suggested that women with perinatal depression, which can occur during or just after pregnancy, have significantly higher risks of developing later cardiovascular disease.

A 2024 study found that in women who had a breast cancer diagnosis in only one breast, the odds of dying from breast cancer didn't change if they had the other breast removed as a precaution.

Osteopenia and osteoporosis both involve a decline in bone density. Osteoporosis is more severe, significantly increasing the risk of fractures. Both conditions can be diagnosed with DEXA scanning, which measures calcium and other minerals in bone.

Over-the-counter menopause test kits detect levels of follicle-stimulating hormone (FSH) in a urine sample. But FSH levels can be high just before ovulation as well as when menopause is approaching, making test results ambiguous.

A new type of nonhormonal medication to prevent hot flashes and night sweats due to menopause, Veozah, was approved by the FDA in 2023. An ad for the drug has useful information, but some key questions are not answered.